World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders

2023110 citationsReviewhybrid Open Access

Authors

Hubertus Himmerich · King's College London

Yael Doreen Lewis · Tel Aviv University

Chiara Conti · University of Chieti-Pescara

Hiba Mutwalli · King's College London

Andreas Karwautz · Medical University of Vienna

Magnus Sjögren · Umeå University

María Mercedes Uribe Isaza ·

Abstract

In BN, fluoxetine, and topiramate, and in BED, LDX and topiramate can be recommended. Despite the published evidence, olanzapine and topiramate have not received marketing authorisation for use in EDs from any medicine regulatory agency.

Topics & Keywords

Eating Disorders and Behaviors Tryptophan and brain disorders

Publication Details

Published in: The World Journal of Biological Psychiatry

Volume 24, Issue 8, pp. 643-706

DOI: 10.1080/15622975.2023.2179663

Field-Weighted Citation Impact: 34.45

Command Palette

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders

Authors

Abstract

Topics & Keywords

Publication Details